The Magazine for Sleep Professionals
Saturday, April 18, 2026
International Biophysics Corporation, manufacturer of the AffloVest is committed to raising awareness of Cystic Fibrosis and the importance of airway clearance therapy in the management of the disease. Over 30,000 people in the U.S. and 70,000 worldwide struggle with the effects of cystic fibrosis every day. There is no cure […]
Electromed, Inc. yesterday announced that Bud Reeves has joined the Company as Vice President of Sales and will oversee all domestic sales initiatives to accelerate revenue growth. Bud has over 20 years of sales and marketing leadership experience in the healthcare industry and brings a history of strong execution of […]
Electromed, Inc. announced the results of an independent, outcome-based clinical study presented during the third annual World Bronchiectasis Conference in Washington D.C. The study’s findings reveal that early use of high-frequency chest wall oscillation (“HFCWO”) therapy with the SmartVest® Airway Clearance System significantly reduced severe exacerbations and hospitalizations among non-cystic […]
Electromed, Inc. maker of airway clearance technologies, announced that the Internal Revenue Service has agreed to refund the company approximately $406,000 related to federal medical device excise taxes paid on revenue associated with the sales of its SmartVest® Airway Clearance System during the company’s tax periods ended June 30, 2014 […]
Electromed, Inc. recently announced the results of a longitudinal outcome-based study published in Respiratory Therapy: The Journal of Pulmonary Technique. The longitudinal study shows that high-frequency chest wall oscillation (“HFCWO”) therapy with the SmartVest® Airway Clearance System significantly reduces bronchiectasis-related exacerbations including the need for antibiotics, emergency department visits, and […]
